1. Home
  2. UTMD vs ENTA Comparison

UTMD vs ENTA Comparison

Compare UTMD & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTMD
  • ENTA
  • Stock Information
  • Founded
  • UTMD 1978
  • ENTA 1995
  • Country
  • UTMD United States
  • ENTA United States
  • Employees
  • UTMD N/A
  • ENTA N/A
  • Industry
  • UTMD Medical/Dental Instruments
  • ENTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • UTMD Health Care
  • ENTA Health Care
  • Exchange
  • UTMD Nasdaq
  • ENTA Nasdaq
  • Market Cap
  • UTMD 185.2M
  • ENTA 164.6M
  • IPO Year
  • UTMD N/A
  • ENTA 2013
  • Fundamental
  • Price
  • UTMD $63.40
  • ENTA $8.85
  • Analyst Decision
  • UTMD
  • ENTA Strong Buy
  • Analyst Count
  • UTMD 0
  • ENTA 4
  • Target Price
  • UTMD N/A
  • ENTA $22.25
  • AVG Volume (30 Days)
  • UTMD 13.1K
  • ENTA 164.5K
  • Earning Date
  • UTMD 10-28-2025
  • ENTA 08-11-2025
  • Dividend Yield
  • UTMD 1.92%
  • ENTA N/A
  • EPS Growth
  • UTMD N/A
  • ENTA N/A
  • EPS
  • UTMD 3.74
  • ENTA N/A
  • Revenue
  • UTMD $38,826,000.00
  • ENTA $64,806,000.00
  • Revenue This Year
  • UTMD N/A
  • ENTA N/A
  • Revenue Next Year
  • UTMD N/A
  • ENTA $1.65
  • P/E Ratio
  • UTMD $16.93
  • ENTA N/A
  • Revenue Growth
  • UTMD N/A
  • ENTA N/A
  • 52 Week Low
  • UTMD $51.26
  • ENTA $4.09
  • 52 Week High
  • UTMD $68.99
  • ENTA $13.37
  • Technical
  • Relative Strength Index (RSI)
  • UTMD 66.95
  • ENTA 60.77
  • Support Level
  • UTMD $60.49
  • ENTA $8.50
  • Resistance Level
  • UTMD $63.10
  • ENTA $9.17
  • Average True Range (ATR)
  • UTMD 1.82
  • ENTA 0.44
  • MACD
  • UTMD 0.36
  • ENTA 0.03
  • Stochastic Oscillator
  • UTMD 91.35
  • ENTA 74.60

About UTMD Utah Medical Products Inc.

Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Share on Social Networks: